College of Psychiatric and Neurologic Pharmacists

Larry Ereshefsky, PharmD, BCPP, FCCP
Executive Vice President and Chief
Scientific Officer
California Clinical Trials
Glendale, California
Adjunct Professor of Pharmacology,
The University of Texas Health Science Center
San Antonio, TX

Larry Ereshefsky, Pharm.D., FCCP, BCPP, is Executive VP and Chief Scientific Officer of California Clinical Trials (CCT). He has held elected/appointed positions with ASHP and ACCP, and is a founding member of the College of Psychiatric and Neurological Pharmacists (CPNP). His Pharm.D. and psychiatric pharmacy residency are from the University of Southern California. He previously was Program Director of The University of Texas Psychiatric Pharmacy Program for over 25 years. He retains an appointment at the University of Texas Health Science Center as Adjunct Professor of Pharmacology and Psychiatry.

At CCT he provides scientific and clinical leadership in the conduct of investigator initiated and sponsored CNS studies, including: PK, bio- and surrogate marker CSF evaluations; polysomnography; Japanese ethnic bridging/pharmacogenetic registry trials; and medical/cardiac safety assessments of novel compounds. Activities include patient/subject evaluations, ratings, rounding, and Principal Investigator responsibilities.

He has published extensively in peer review journals, served on the FDA Advisory Committee for Psychopharmacologic Drugs and on the USP-DI Psychiatry Panel. Hobbies include sailing, digital photography, astronomy, white water rafting, and reading fantasy/hard science fiction.